Skip to Primary Navigation

FDA launches program to bolster domestic drug manufacturing

A photo of a sign in front of the FDA headquarters.
Photo: Sarah Silbiger/Getty Images

The PreCheck program aims to make it significantly less onerous to set up domestic manufacturing plants provided they align with US national priorities.

The US Food and Drug Administration (FDA) officially launched its FDA PreCheck pilot program and is now accepting requests from drug manufacturers.

Initially announced in August, the FDA PreCheck program is designed to make it significantly less onerous to establish domestic manufacturing plants by increasing regulatory predictability, facilitating the construction

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience